The Cytel blog keeps you up to speed with the latest developments in biostatistics and clinical biometrics.

Cytel Congratulates Lipopharma and CLINGLIO Consortium on Recent Grant Award

February 27, 2018

We extend our congratulations to Lipopharma and the CLINGLIO project consortium on their recent 6,15M€ grant award by the European Union’s Horizon 2020 program. Led by Lipopharma, the multinational consortium brings together 12 academic and industry organizations from Europe, Israel, and the USA.

Read More

Innovative Phase 3 Adaptive Enrichment Design in Oncology

December 2, 2016

At a recent Pfizer/ Cytel seminar on rare disease and oncology development, Cytel’s Lingyun Liu presented innovative work on a patient enrichment design. In this blog, we share some design and operational considerations. This approach can help mitigate against underpowering of a clinical trial where there is uncertainty and heterogeneity of treatment effect among subpopulations.

Read More